Company / Operating Income
NOVAVAX INC Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$452.8M
FY2025
5-year range
-$1.7B / $452.8M
FY2021-FY2025
Trend
+281.9%
vs FY2024
Sector context
#17 of 204
Health Care
What the data says
Operating Income changed +282% YoY in FY2025, a notable deviation from the 9-year average annual change of -21%.
Based on SEC 10-K filings.
$453M in FY2025. Top quartile in the Health Care sector.
Improved from -$567M to $453M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 8% in Health CareTop 8% of 204This company $452.8M Sector average $107.8M
▼
+320.2% above sector average
Key checks
Key Insights
- In FY2025, operating income increased 281.9% year-over-year.
- Ranks #17 out of 204 companies in the Health Care sector.
- Lowest operating income in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.87 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.5%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $452.8M | +281.9% |
| FY2024 | -$248.9M | +56.1% |
| FY2023 | -$566.5M | -35.9% |
| FY2022 | -$416.7M | +75.3% |
| FY2021 | -$1.7B | -304.7% |
| FY2020 | -$416.7M | -142.7% |
| FY2019 | -$171.7M | +36.2% |
| FY2018 | -$269.1M | -71.2% |
| FY2017 | -$157.2M | -87.9% |
| FY2016 | -$83.7M | -59.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026